换一批
换一批CNI withdrawal for post-transplant lymphoproliferative disorders in kidney transplant is an independent risk factor for graft failure and mortality.
作者：
主题词
成年人(Adult);老年人(Aged);抗体, 单克隆, 鼠源性(Antibodies, Monoclonal, Murine-Derived);抗肿瘤药(Antineoplastic Agents);肌酸(Creatine);药物替代(Drug Substitution);爱泼斯坦巴尔病毒感染(Epstein-Barr Virus Infections);女(雌)性(Female);法国(France);肾小球滤过率(Glomerular Filtration Rate);移植物排斥(Graft Rejection);移植物存活(Graft Survival);人类(Humans);免疫减弱宿主(Immunocompromised Host);免疫抑制剂(Immunosuppressive Agents);肾(Kidney);肾移植(Kidney Transplantation);淋巴组织增殖性疾病(Lymphoproliferative Disorders);男(雄)性(Male);中年人(Middle Aged);胰腺移植(Pancreas Transplantation);手术后并发症(Postoperative Complications);比例危险度模型(Proportional Hazards Models);放射疗法, 辅助(Radiotherapy, Adjuvant);肾透析(Renal Dialysis);肾功能不全(Renal Insufficiency);回顾性研究(Retrospective Studies);危险因素(Risk Factors);青年人(Young Adult)
DOI
10.1111/tri.12375
PMID
24964147
发布时间
2022-03-17
- 浏览93
Transplant international
956-65页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
